FilingReader Intelligence

Fosun Pharma sells stake in subsidiary, updates related party deals

April 11, 2025 at 05:19 PM UTC•By FilingReader AI

Shanghai Fosun Pharmaceutical Group (SSE:600196) announced the sale of portions of its equity in Shanghai Fuxing Health to Fosun High Technology, Li Fan, and Guan Xiaohui for CNY 13,993,682, CNY 12,497,806 and CNY 48,254 respectively. This transaction reduces Fosun Pharma's stake in Shanghai Fuxing Health from 100% to 45%, changing its classification from a consolidated subsidiary to an associated company.

This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com

Primary Source Document

Fosun Pharma's announcement on repurchasing and cancelling some of its A-share restricted stocks that have not been released from the sales restrictionApril 11, 2025 at 08:00 AM UTC

Supplementary Source Documents

Fosun Pharma's announcement on repurchasing and cancelling some of its A-share restricted stocks that have not been released from the sales restrictionApril 11, 2025 at 10:39 AM UTC

Shanghai Fosun Pharmaceutical Group

SSE:600196•Shanghai Stock Exchange

PharmaceuticalsShanghai Blue Chip

RSS feed for Shanghai Fosun Pharmaceutical Group

News Alerts

Get instant email alerts when Shanghai Fosun Pharmaceutical Group publishes news

Free account required • Unsubscribe anytime

Browse RSS Feeds

Filing Activity Timeline

View Complete Filing History →